Tabernanthalog (TBG) — The Future of Addiction Research Is Here
The science of addiction treatment is shifting and tabernanthalog effects are at the heart of that change. If you are a researcher or laboratory professional curious about this groundbreaking iboga analogue, here is a quick overview of why TBG is generating so much excitement in 2025 and 2026.
What Is Tabernanthalog?
Tabernanthalog or TBG is a synthetic, water-soluble ibogaine analogue engineered by Delix Therapeutics to promote neuroplasticity and reduce addictive behavior without causing hallucinations. It was designed from the ground up to be safer, more scalable, and more research-friendly than ibogaine itself.
Tabernanthalog Effects That Matter
Preclinical studies have revealed remarkable tabernanthalog effects including reduced alcohol- and opioid-seeking behavior, rapid antidepressant-like activity, and significant promotion of dendritic spine growth all without the cardiac risks or hallucinogenic experience associated with ibogaine. A single dose has shown effects lasting several days in animal models.
DLX-007 Clinical Trial A Historic Milestone
Tabernanthalog Delix Therapeutics has advanced TBG into human trials under the designation DLX-007. The tabernanthalog DLX-007 clinical trial is currently evaluating safety and tolerability in humans making this one of the most watched programs in psychedelic medicine today.
Is Tabernanthalog Legal?
Yes in most jurisdictions. Tabernanthalog is not a scheduled substance in the US or EU, making it legal to buy tabernanthalog for legitimate laboratory research. Always verify the tabernanthalog legal status in your country before ordering.
Buy Tabernanthalog Online
Ready to advance your research? We offer research-grade TBG powder with a Certificate of Analysis, discreet packaging, and bulk pricing for institutions. {
Comments
Post a Comment